INSIDER · CIK 1326969
Bedrosian Camille L
Chief Medical Officer at Amylyx Pharmaceuticals, Inc. (AMLX) · Director at Crinetics Pharmaceuticals, Inc. (CRNX)
↗3 Form 4 rows in the window
Covers original filings from Aug 1, 2026 to Oct 29, 2026. Older trades and amendments are in the SEC history.
$0.00Bought on the market
$325KSold on the market
2Companies
Sep 14, 2026Latest filing
| Company | Title | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 14, 202616:00 | Sep 10, 2026 | AMLXAmylyx Pharmaceuticals, Inc. | Chief Medical Officer | S · Sell | $32.40 | −10,028 | 278,064 | -3% | −$325K | ||
| Sep 1, 202617:00 | Sep 1, 2026 | CRNXCrinetics Pharmaceuticals, Inc. | Director | D · To issuer | $85.00 | −22,225 | 0 | -100% | $1.9M | ||
| Aug 20, 202621:00 | Aug 18, 2026 | AMLXAmylyx Pharmaceuticals, Inc. | Chief Medical Officer | A · Grant | — | +22,807 | 288,092 | +9% | — |